Ahmed Mohyeldin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ahmed Mohyeldin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Gretchen M. Koller
Department of Neurosurgery, College of Osteopathic Medicine, Kansas City University, Kansas City, Missouri, United States
1 shared publication - Justin F. Fraser
Department of Neurosurgery, University of Kentucky, Lexington, Kentucky, USA
1 shared publication - Michael W. Kortz
Department of Neurosurgery, University of Colorado School of Medicine, Aurora, Colorado, United States
1 shared publication - Morgan Turnow
Department of Orthopedics, OhioHealth, Columbus, OH 43228, USA
1 shared publication - Nolan James Brown
Department of Neurosurgery, University of California Irvine, Orange, CA, USA
1 shared publication - Shelly Sharma
Department of Neurosurgery, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, United States
1 shared publication
Latest Publications
- Open Access
- 28 October 2022
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 13, 494
Surgical management of petrous apex cholesteatomas in the pediatric population: A systematic review
Background: Cholesteatomas are growths of squamous epithelium that can form inside the middle ear and mastoid cavity and damage nearby structures causing hearing loss when located at the petrous apex. The primary goal of petrous apex cholesteatoma resection is gross total removal with tympanoplasty and canal-wall up or canal-wall down tympanomastoidectomy. At present, there is no definitive surgical approach supported by greater than level 4 evidence in the literature to date. Methods: A systematic review was conducted utilizing PubMed, Embase, and Scopus databases. Articles were screened and selected to be reviewed in full text. The articles that met inclusion criteria were reviewed for relevant data. Data analysis, means, and standard deviations were calculated using Microsoft Excel. Results: After screening, five articles were included in the systematic review. There were a total of eight pediatric patients with nine total cholesteatomas removed. Conductive hearing loss was the most common (77%) presenting symptom. Perforations were noted in seven ears (86%). Recurrence was noted in 50% of patients with an average recurrence rate of 3.5 years (SD = 1.73). Average length of follow-up was 32.6 months (SD = 21.7). Canal-wall up was the most utilized technique (60%) and there were zero noted surgical complications. Five of the seven (71%) patients that experienced hearing loss from perforation noted improved hearing. Conclusion: Due to its rarity, diagnostic evaluation and treatment can vary. Further, multi-institutional investigation is necessary to develop population-level management protocols for pediatric patients affected by petrous apex cholesteatomas.
- 28 October 2022
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 13, 494
Open AccessSurgical management of petrous apex cholesteatomas in the pediatric population: A systematic review
Background: Cholesteatomas are growths of squamous epithelium that can form inside the middle ear and mastoid cavity and damage nearby structures causing hearing loss when located at the petrous apex. The primary goal of petrous apex cholesteatoma resection is gross total removal with tympanoplasty and canal-wall up or canal-wall down tympanomastoidectomy. At present, there is no definitive surgical approach supported by greater than level 4 evidence in the literature to date. Methods: A systematic review was conducted utilizing PubMed, Embase, and Scopus databases. Articles were screened and selected to be reviewed in full text. The articles that met inclusion criteria were reviewed for relevant data. Data analysis, means, and standard deviations were calculated using Microsoft Excel. Results: After screening, five articles were included in the systematic review. There were a total of eight pediatric patients with nine total cholesteatomas removed. Conductive hearing loss was the most common (77%) presenting symptom. Perforations were noted in seven ears (86%). Recurrence was noted in 50% of patients with an average recurrence rate of 3.5 years (SD = 1.73). Average length of follow-up was 32.6 months (SD = 21.7). Canal-wall up was the most utilized technique (60%) and there were zero noted surgical complications. Five of the seven (71%) patients that experienced hearing loss from perforation noted improved hearing. Conclusion: Due to its rarity, diagnostic evaluation and treatment can vary. Further, multi-institutional investigation is necessary to develop population-level management protocols for pediatric patients affected by petrous apex cholesteatomas.